 |
Video: What is a Stock Split?
|
 |
Jaguar Health is a pharmaceuticals company that develops plant-based, sustainably derived prescription medicines for people and animals with gastrointestinal distress, such as chronic, debilitating diarrhea. Co.'s subsidiary, Napo Pharmaceuticals, Inc. (Napo), develops and commercializes proprietary plant-based human pharmaceuticals. Napo's marketed drug Mytesi (crofelemer 125 mg delayed-release tablets) is an oral botanical drug product for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Co.'s Canalevia-CA1 (crofelemer delayed-release tablets) drug is an oral plant-based prescription product to treat chemotherapy-induced diarrhea in dogs. According to our JAGX split history records, Jaguar Health has had 4 splits. | |
 |

Jaguar Health (JAGX) has 4 splits in our JAGX split history database. The first split for JAGX took place on June 01, 2018. This was a 1 for 15 reverse split, meaning for each 15 shares of JAGX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split. JAGX's second split took place on June 07, 2019. This was a 1 for 7 reverse split, meaning for each 7 shares of JAGX owned pre-split, the shareholder now owned 1 share. For example, a 66.6666666666667 share position pre-split, became a 9.52380952380952 share position following the split. JAGX's third split took place on September 08, 2021. This was a 1 for 3 reverse split, meaning for each 3 shares of JAGX owned pre-split, the shareholder now owned 1 share. For example, a 9.52380952380952 share position pre-split, became a 3.17460317460317 share position following the split. JAGX's 4th split took place on January 23, 2023. This was a 1 for 75 reverse split, meaning for each 75 shares of JAGX owned pre-split, the shareholder now owned 1 share. For example, a 3.17460317460317 share position pre-split, became a 0.0423280423280423 share position following the split.
When a company such as Jaguar Health conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the JAGX split history from start to finish, an original position size of 1000 shares would have turned into 0.0423280423280423 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Jaguar Health shares, starting with a $10,000 purchase of JAGX, presented on a split-history-adjusted basis factoring in the complete JAGX split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/13/2015 |
|
End date: |
11/28/2023 |
|
Start price/share: |
$160,177.50 |
|
End price/share: |
$0.35 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-100.00% |
|
Average Annual Total Return: |
-78.23% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$0.02 |
|
Years: |
8.55 |
|
|
 |
Date |
Ratio |
06/01/2018 | 1 for 15 | 06/07/2019 | 1 for 7 | 09/08/2021 | 1 for 3 | 01/23/2023 | 1 for 75 |
|
 |